Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming

NCT01785121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 605

Last updated 2019-04-03

No results posted yet for this study

Summary

The study objectives are to determine the effectiveness of structured access to a Wii game computer compared to motivational support only in heart failure patients on exercise capacity and daily activity. Secondly, to determine the effectiveness of structured access to a Wii game computer compared to motivational support only in heart failure patients on the combined endpoint of death, readmission and quality of life.

The following research questions will be addressed:

* What is the effectiveness of structured introduction and access to a Wii game computer in patients with heart failure to improve their exercise capacity compared to patients with heart failure in a control group who only receive motivational support?
* What is the effectiveness of structured introduction and access to a Wii game computer in patients with heart failure compared to patients with heart failure in a control group who only receive motivational support to increase their daily physical activity, decrease health care use and improve quality of life?
* What are experiences of heart failure patients and how is their exercise motivation when they are introduced and instructed to play with a Wii game computer?

Conditions

Interventions

BEHAVIORAL

Structured access to a Wii game computer (Wii)

Patients who are randomized to the Wii group will be introduced to the Nintendo Wii game computer in an introduction lesson of approximately two hours and the Wii will be installed at home. During the first three months after inclusion, patients will be phoned after 2, 4, 8, 12 weeks to discuss their experiences with the Wii or to solve possible problems

BEHAVIORAL

Motivational support only

The control group receives an protocolized exercise advice and telephone follow-up at 2, 4, 8 and 12 weeks

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV
  • The Swedish Heart and Lung Association

    collaborator OTHER
  • Swedish Heart Lung Foundation

    collaborator OTHER
  • Vardalinstitutet The Swedish Institute for Health Sciences

    collaborator OTHER
  • Medical Research Council of Southeast Sweden

    collaborator OTHER_GOV
  • Swedish Council for Working Life and Social Research

    collaborator OTHER
  • Linkoeping University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785121 on ClinicalTrials.gov